A statewide project including the expertise of Professor David Mott has Wisconsin pharmacies re-thinking prescription labels.
Research
Breaking the Opioid Cycle
In the first in a three-part series exploring how School of Pharmacy researchers are curbing the opioid epidemic, faculty are building a toolkit for pharmacists to get involved with opioid use disorder treatment, and paving the way for an opioid misuse vaccine.
Education Empowers Epilepsy Patients
A patient education-focused research project led by Professor Barry Gidal and Assistant Professor Amanda Margolis explores how information can increase epilepsy medication adherence.
Two Faculty Honored with Prestigious Vilas Awards
Vilas Investigator Awards allow Weiping Tang and Jiaoyang Jiang to expand their research labs to pursue new opportunities.
Antibiotic Resistance Across Wisconsin Revealed by New Maps
Assistant Scientist Laurel Legenza’s antimicrobial resistance mapping tool, the AMR Tracker, reaches a new milestone and welcomes a new partnership.
New Faculty Position Brightens the Future of Pharmacy’s History
The School of Pharmacy welcomes Lucas Richert as the George Urdang Chair in the History of Pharmacy and associate professor in the Social and Administrative Sciences Division.
Faculty Author Q&A: ‘Strange Trips’
Associate Professor Luc Richert shares insight on his latest book about the evolving perceptions of drugs
$30 Million NIH Award will Help Tackle the Toughest Pathogens
Professor Tim Bugni and his colleagues receive $30 million grant from the NIH to take aim at the growing threat of multi-drug-resistant pathogens for which few — or no — treatment options exist.
School Enhances Training to Improve Health Services Research in Pharmacy
The School of Pharmacy’s Social and Administrative Sciences in Pharmacy graduate degree program gets a new name and new courses to better set students up for research success.
UW–Madison School of Pharmacy’s Jennifer Golden Designs Promising New Compounds To Fight Deadly Mosquito-Transmitted Viruses
The School of Pharmacy makes a breakthrough in creating new small molecules that penetrate into the brain where the equine encephalitis viruses reside and interfere with viral replication to stop EEV. The research is funded by a new, five-year $21 million award from the National Institutes of Health (NIH).